Ovarian Cancer Clinical Trial

Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy

Summary

Prospective, multi-center, non-randomized study to assess the ability of the Cytuity device to collect cell samples from the fallopian tube that can be evaluated for the presence or absence of malignancy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Subject is medically cleared for surgery
Subject is scheduled to undergo salpingo-oophorectomy or salpingectomy for a pelvic mass suspicious for malignancy
Subject must be 18 years of age
Subject must be able to provide informed consent

Exclusion Criteria:

Contraindication to hysteroscopy
Acute pelvic inflammatory disease
Active or recent lower pelvic infection
Pregnancy
Delivery or termination of a pregnancy in the past 6 weeks
Known tubal obstruction
Tubal ligation
Invasive carcinoma of the cervix or endometrium
Intolerance of anesthesia

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

150

Study ID:

NCT03593681

Recruitment Status:

Completed

Sponsor:

Boston Scientific Corporation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 10 Locations for this study

See Locations Near You

Scripps Clinic Medical Group
San Diego California, 92103, United States
Kaiser Permanente San Francisco Medical Center
San Francisco California, 94115, United States
Mayo Clinic
Jacksonville Florida, 32224, United States
Mayo Clinic
Rochester Minnesota, 55905, United States
New York Presbyterian Hospital
New York New York, 10032, United States
Pennsylvania Hospital
Philadelphia Pennsylvania, 19107, United States
Vanderbilt University Medical Center
Nashville Tennessee, 37232, United States
Baylor Scott & White Research Institute
Fort Worth Texas, 76104, United States
University of Virginia
Charlottesville Virginia, 22908, United States
Swedish Health Services
Seattle Washington, 98104, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

150

Study ID:

NCT03593681

Recruitment Status:

Completed

Sponsor:


Boston Scientific Corporation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider